Table 5 Cost and effectiveness of three strategies for tuberculosis control in Zambian newborns over 30 years, per 100,000 newborns.
From: Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
Strategies | Total Costs | Direct Costs | Indirect Costs | TB Cases | TB Mortality | |
|---|---|---|---|---|---|---|
Ranked from least to most expensive with respect to total cost | $million | $million | $million | Â | Â | |
After 5 years | Novel TB vaccine at birth | 1.522 | 0.715 | 0.806 | 1,233 | 611 |
| Â | Status quo | 1.742 | 0.756 | 0.986 | 1,419 | 687 |
| Â | Novel TB vaccine at birth with Booster | 1.783 | 0.977 | 0.806 | 1,233 | 611 |
After 10 years | Novel TB vaccine at birth | 3.568 | 1.222 | 2.346 | 2,480 | 1,378 |
| Â | Novel TB vaccine at birth with Booster | 3.830 | 1.484 | 2.346 | 2,480 | 1,378 |
| Â | Status quo | 4.007 | 1.278 | 2.729 | 2,690 | 1,473 |
After 20 years | Novel TB vaccine at birth with Booster | 7.795 | 2.164 | 5.631 | 4,142 | 2,729 |
| Â | Novel TB vaccine at birth | 8.003 | 1.993 | 6.010 | 4,351 | 2,859 |
| Â | Status quo | 8.645 | 2.047 | 6.597 | 4,552 | 2,950 |
After 30 years | Novel TB vaccine at birth with Booster | 10.869 | 2.549 | 8.320 | 5,062 | 3,711 |
| Â | Novel TB vaccine at birth | 11.294 | 2.377 | 8.917 | 5,261 | 3,836 |
| Â | Status quo | 12.067 | 2.431 | 9.636 | 5,460 | 3,927 |